BioXcel Therapeutics, Inc. ( BTAI) - Stock Earnings
BTAI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
BTAI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -30.9 million USD | 98000 USD |
| 2025Q4 | -12.5 million USD | 256000 USD |
| 2026Q1 | -12.7 million USD | 206000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BTAI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -179.1 million USD | 1.4 million USD |
| 2024 | -59.6 million USD | 2.3 million USD |
| 2025 | -69.9 million USD | 642000 USD |
| 2026 Est. | — | — |
BTAI
Price: $0.85
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 510800
Market Capitalization: 42.6 million